| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |